학술논문

C65 - Are anti-HER2 agents the best choice in metastatic breast cancer with an HER2 positive switch from primary tumour? A retrospective multi institution analysis of clinical-pathological characteristics and outcomes
Document Type
Article
Source
In Annals of Oncology October 2017 28 Supplement 6:vi42-vi43
Subject
Language
ISSN
0923-7534